(Q44415952)

2 December 2017

title

Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The framingham heart study (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

10 November 2022

0 references

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

10 November 2022

3

D. Levy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729324

10 November 2022

author name string

M. S. Lauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729324

10 November 2022

K. M. Anderson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729324

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:073510979290063S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

https://api.elsevier.com/content/article/PII:073510979290063S?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Journal of the American College of Cardiology

10 November 2022

published in

1 reference

2 December 2017

volume

19

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

130-134

1 reference

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study

10 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

10 November 2022

Hypertension and Obesity

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

The relation of adiposity to blood pressure and development of hypertension. The Framingham study

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Dimorphic cardiac adaptation to obesity and arterial hypertension

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study)

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

BP as a Determinant of Cardiac Left Ventricular Muscle Mass

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Cardiovascular effects of obesity and hypertension

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Epidemiological approaches to heart disease: the Framingham Study

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

An approach to longitudinal studies in a community: the Framingham Study

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

An investigation of coronary heart disease in families. The Framingham offspring study

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

The cardiomyopathy of obesity

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Wall stress and patterns of hypertrophy in the human left ventricle

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Racial differences in cardiac adaptation to essential hypertension determined by echocardiography indexes

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Two-dimensional echocardiographic evaluation of the size, function and shape of the left ventricle in chronic aortic regurgitation: Comparison with radionuclide angiography

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Relation of alcohol intake to left ventricular mass: The Framingham Study

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress

10 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Obesity and congestive heart failure

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

Obesity and cardiovascular disease: The Framingham study

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90063-S

10 November 2022

Identifiers

1 reference

2 December 2017

1 reference